Insider Transactions in Q3 2022 at 10x Genomics, Inc. (TXG)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 14
2022
|
Justin J. Mc Anear |
BUY
Grant, award, or other acquisition
|
Direct |
20,297
+20.57%
|
-
|
|
Sep 14
2022
|
Benjamin J. Hindson |
BUY
Grant, award, or other acquisition
|
Direct |
33,828
+13.32%
|
-
|
|
Sep 14
2022
|
James Wilbur Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
95,839
+50.0%
|
-
|
|
Sep 14
2022
|
Sridhar Kosaraju |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.64%
|
$110,000
$11.48 P/Share
|
|
Sep 12
2022
|
Serge Saxonov Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+1.16%
|
$11,500
$1.2 P/Share
|
|
Aug 23
2022
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,715
-0.28%
|
$95,025
$35.19 P/Share
|
|
Aug 23
2022
|
Justin J. Mc Anear |
SELL
Open market or private sale
|
Direct |
987
-1.67%
|
$34,545
$35.19 P/Share
|
|
Aug 23
2022
|
Benjamin J. Hindson |
SELL
Open market or private sale
|
Direct |
1,292
-0.69%
|
$45,220
$35.19 P/Share
|